Tyra Biosciences Ownership 2024 | Who Owns Tyra Biosciences Now?
Institutional Ownership
17.76%
Insider Ownership
4.70%
Retail Ownership
77.54%
Institutional Holders
25.00
Tyra Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24.24% | 0.25% | 10,416,609 | 3,180,155 | 43.95% | 170,832,388 | Mar 31, 2024 |
| BOXER CAPITAL, LLC | 15.01% | 5.22% | 6,448,359 | - | - | 105,753,088 | Mar 31, 2024 |
| BVF INC/IL | 10.85% | 2.10% | 4,661,194 | 1,921,599 | 70.14% | 76,443,582 | Mar 31, 2024 |
| CANAAN PARTNERS XI LLC | 10.26% | 79.77% | 4,409,991 | - | - | 72,323,852 | Mar 31, 2024 |
| NEXTECH INVEST LTD. | 9.44% | 10.54% | 4,055,861 | 1,537,279 | 61.04% | 66,516,120 | Mar 31, 2024 |
| FMR LLC | 9.26% | 0.00% | 3,977,208 | 1,208,512 | 43.65% | 65,226,211 | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 4.63% | 2.58% | 1,989,103 | - | - | 32,621,289 | Mar 31, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 3.24% | 2.49% | 1,393,329 | - | - | 22,850,596 | Mar 31, 2024 |
| BLACKROCK INC. | 2.43% | 0.00% | 1,044,225 | 79,191 | 8.21% | 17,125,289 | Mar 31, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 2.19% | 3.45% | 939,298 | 384,319 | 69.25% | 15,404,487 | Mar 31, 2024 |
| VANGUARD GROUP INC | 2.09% | 0.00% | 899,800 | 140,833 | 18.56% | 14,756,720 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.94% | 0.58% | 832,220 | -194,200 | -18.92% | 13,648,408 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.79% | 0.23% | 768,638 | 768,638 | 100.00% | 12,605,663 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.56% | 0.19% | 669,159 | 309,159 | 85.88% | 10,974,208 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.25% | 2.62% | 535,741 | 535,741 | 100.00% | 8,786,152 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.20% | 0.88% | 515,190 | 175,000 | 51.44% | 8,449,116 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.97% | 0.00% | 416,808 | 83,339 | 24.99% | 6,837,116 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.89% | 0.94% | 381,210 | 381,210 | 100.00% | 6,251,844 | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.89% | 0.00% | 380,597 | -21,109 | -5.25% | 6,241,791 | Mar 31, 2024 |
| STATE STREET CORP | 0.68% | 0.00% | 292,234 | 26,880 | 10.13% | 4,792,638 | Mar 31, 2024 |
Tyra Biosciences's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 24.24% of the company's total share outstanding, currently valued at $170.83M. The top 10 institutional shareholders own together 91.55% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CANAAN PARTNERS XI LLC | 10.26% | 79.77% | 4,409,991 | - | - | 72,323,852 | Mar 31, 2024 |
| NEXTECH INVEST LTD. | 9.44% | 10.54% | 4,055,861 | 1,537,279 | 61.04% | 66,516,120 | Mar 31, 2024 |
| BOXER CAPITAL, LLC | 15.01% | 5.22% | 6,448,359 | - | - | 105,753,088 | Mar 31, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 2.19% | 3.45% | 939,298 | 384,319 | 69.25% | 15,404,487 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.25% | 2.62% | 535,741 | 535,741 | 100.00% | 8,786,152 | Mar 31, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 4.63% | 2.58% | 1,989,103 | - | - | 32,621,289 | Mar 31, 2024 |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 3.24% | 2.49% | 1,393,329 | - | - | 22,850,596 | Mar 31, 2024 |
| BVF INC/IL | 10.85% | 2.10% | 4,661,194 | 1,921,599 | 70.14% | 76,443,582 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.89% | 0.94% | 381,210 | 381,210 | 100.00% | 6,251,844 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.20% | 0.88% | 515,190 | 175,000 | 51.44% | 8,449,116 | Mar 31, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.94% | 0.58% | 832,220 | -194,200 | -18.92% | 13,648,408 | Mar 31, 2024 |
| AUOUR INVESTMENTS LLC | 0.20% | 0.51% | 85,020 | - | - | 1,394,328 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.36% | 0.26% | 152,968 | 152,968 | 100.00% | 2,508,675 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 24.24% | 0.25% | 10,416,609 | 3,180,155 | 43.95% | 170,832,388 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.79% | 0.23% | 768,638 | 768,638 | 100.00% | 12,605,663 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.56% | 0.19% | 669,159 | 309,159 | 85.88% | 10,974,208 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.07% | 0.11% | 28,300 | 28,300 | 100.00% | 464,120 | Mar 31, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.05% | 0.04% | 20,259 | 20,259 | 100.00% | 332,248 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.63% | 0.03% | 272,150 | 272,150 | 100.00% | 4,463,000 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.47% | 0.03% | 203,709 | - | - | 3,340,828 | Mar 31, 2024 |
The largest Tyra Biosciences shareholder by % of total assets is CANAAN PARTNERS XI LLC. The company owns 4.41M shares of Tyra Biosciences (TYRA), representing 79.77% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 24.24% | 0.25% | 10,416,609 | 3,180,155 | 43.95% | 170,832,388 | Mar 31, 2024 |
| BVF INC/IL | 10.85% | 2.10% | 4,661,194 | 1,921,599 | 70.14% | 76,443,582 | Mar 31, 2024 |
| NEXTECH INVEST LTD. | 9.44% | 10.54% | 4,055,861 | 1,537,279 | 61.04% | 66,516,120 | Mar 31, 2024 |
| FMR LLC | 9.26% | 0.00% | 3,977,208 | 1,208,512 | 43.65% | 65,226,211 | Mar 31, 2024 |
| ORBIMED ADVISORS LLC | 1.79% | 0.23% | 768,638 | 768,638 | 100.00% | 12,605,663 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.25% | 2.62% | 535,741 | 535,741 | 100.00% | 8,786,152 | Mar 31, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 2.19% | 3.45% | 939,298 | 384,319 | 69.25% | 15,404,487 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.89% | 0.94% | 381,210 | 381,210 | 100.00% | 6,251,844 | Mar 31, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.56% | 0.19% | 669,159 | 309,159 | 85.88% | 10,974,208 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.63% | 0.03% | 272,150 | 272,150 | 100.00% | 4,463,000 | Mar 31, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.20% | 0.88% | 515,190 | 175,000 | 51.44% | 8,449,116 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.36% | 0.26% | 152,968 | 152,968 | 100.00% | 2,508,675 | Mar 31, 2024 |
| VANGUARD GROUP INC | 2.09% | 0.00% | 899,800 | 140,833 | 18.56% | 14,756,720 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.97% | 0.00% | 416,808 | 83,339 | 24.99% | 6,837,116 | Mar 31, 2024 |
| BLACKROCK INC. | 2.43% | 0.00% | 1,044,225 | 79,191 | 8.21% | 17,125,289 | Mar 31, 2024 |
| OPPENHEIMER & CO INC | 0.14% | 0.02% | 59,576 | 59,576 | 100.00% | 977,046 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.13% | 0.00% | 54,400 | 54,400 | 100.00% | 892,000 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.10% | 0.00% | 41,742 | 41,742 | 100.00% | 684,569 | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.35% | 0.00% | 152,212 | 41,675 | 37.70% | 2,496,277 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.07% | 0.11% | 28,300 | 28,300 | 100.00% | 464,120 | Mar 31, 2024 |
As of Mar 31 2024, Tyra Biosciences's largest institutional buyer is RA CAPITAL MANAGEMENT, L.P.. The company purchased 3.18M stocks of TYRA, valued at $170.83M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.94% | 0.58% | 832,220 | -194,200 | -18.92% | 13,648,408 | Mar 31, 2024 |
| ECOR1 CAPITAL, LLC | - | - | - | -137,014 | -100.00% | - | Mar 31, 2024 |
| IKARIAN CAPITAL, LLC | 0.00% | 0.00% | 501 | -47,669 | -98.96% | 8,216 | Mar 31, 2024 |
| MARINER, LLC | - | - | - | -22,164 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | 0.89% | 0.00% | 380,597 | -21,109 | -5.25% | 6,241,791 | Mar 31, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -14,400 | -100.00% | - | Mar 31, 2024 |
| SEPIO CAPITAL, LP | - | - | - | -10,625 | -100.00% | - | Mar 31, 2024 |
| LPL FINANCIAL LLC | - | - | - | -10,500 | -100.00% | - | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.05% | 0.00% | 19,643 | -10,358 | -34.53% | 322,145 | Mar 31, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -10,253 | -100.00% | - | Mar 31, 2024 |
| BARCLAYS PLC | 0.02% | 0.00% | 9,850 | -9,377 | -48.77% | 161,000 | Mar 31, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -8,867 | -100.00% | - | Mar 31, 2024 |
| AJOVISTA, LLC | - | - | - | -4,235 | -100.00% | - | Mar 31, 2024 |
| ROYAL BANK OF CANADA | 0.00% | - | 320 | -3,924 | -92.46% | 5,000 | Mar 31, 2024 |
| VICTORY CAPITAL MANAGEMENT INC | 0.11% | 0.00% | 48,090 | -2,130 | -4.24% | 788,676 | Mar 31, 2024 |
| FEDERATED HERMES, INC. | 0.00% | - | 713 | -1,357 | -65.56% | 11,693 | Mar 31, 2024 |
| AMALGAMATED BANK | 0.00% | 0.00% | 424 | -1,021 | -70.66% | 7,000 | Mar 31, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 1,406 | -896 | -38.92% | 23,058 | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | 0.00% | 144 | -860 | -85.66% | 2,362 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.24% | 0.00% | 101,788 | -648 | -0.63% | 1,669,324 | Mar 31, 2024 |
As of Mar 31 2024, Tyra Biosciences's biggest institutional seller is FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The company sold -0.19M shares of TYRA, valued at $13.65M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 1.79% | 0.23% | 768,638 | 768,638 | 100.00% | 12,605,663 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.25% | 2.62% | 535,741 | 535,741 | 100.00% | 8,786,152 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.89% | 0.94% | 381,210 | 381,210 | 100.00% | 6,251,844 | Mar 31, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.63% | 0.03% | 272,150 | 272,150 | 100.00% | 4,463,000 | Mar 31, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | 0.36% | 0.26% | 152,968 | 152,968 | 100.00% | 2,508,675 | Mar 31, 2024 |
| OPPENHEIMER & CO INC | 0.14% | 0.02% | 59,576 | 59,576 | 100.00% | 977,046 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.13% | 0.00% | 54,400 | 54,400 | 100.00% | 892,000 | Mar 31, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.10% | 0.00% | 41,742 | 41,742 | 100.00% | 684,569 | Mar 31, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.07% | 0.11% | 28,300 | 28,300 | 100.00% | 464,120 | Mar 31, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | 0.05% | 0.04% | 20,259 | 20,259 | 100.00% | 332,248 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.04% | 0.00% | 16,887 | 16,887 | 100.00% | 276,947 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.04% | 0.00% | 16,789 | 16,789 | 100.00% | 275,340 | Mar 31, 2024 |
| JUMP FINANCIAL, LLC | 0.04% | 0.01% | 15,159 | 15,159 | 100.00% | 248,607 | Mar 31, 2024 |
| FISHMAN JAY A LTD/MI | 0.03% | 0.03% | 15,000 | 15,000 | 100.00% | 246,000 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.03% | - | 14,077 | 14,077 | 100.00% | 230,863 | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | 0.03% | 0.00% | 13,317 | 13,317 | 100.00% | 218,399 | Mar 31, 2024 |
| PDT PARTNERS, LLC | 0.03% | 0.02% | 12,174 | 12,174 | 100.00% | 199,654 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.01% | - | 3,700 | 3,700 | 100.00% | 60,680 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.00% | 0.02% | 1,345 | 1,345 | 100.00% | 22,058 | Mar 31, 2024 |
| STRS OHIO | 0.00% | - | 700 | 700 | 100.00% | 11,000 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.00% | - | 600 | 600 | 100.00% | 9,840 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 2 | 2 | 100.00% | 32 | Mar 31, 2024 |
Tyra Biosciences's largest new institutional shareholder by number of shares is ORBIMED ADVISORS LLC, purchased 768.64K shares, valued at $12.61M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -137,014 | -100.00% | - | Mar 31, 2024 |
| MARINER, LLC | - | - | - | -22,164 | -100.00% | - | Mar 31, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -14,400 | -100.00% | - | Mar 31, 2024 |
| SEPIO CAPITAL, LP | - | - | - | -10,625 | -100.00% | - | Mar 31, 2024 |
| LPL FINANCIAL LLC | - | - | - | -10,500 | -100.00% | - | Mar 31, 2024 |
| ARTIA GLOBAL PARTNERS LP | - | - | - | -10,253 | -100.00% | - | Mar 31, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | - | - | - | -8,867 | -100.00% | - | Mar 31, 2024 |
| AJOVISTA, LLC | - | - | - | -4,235 | -100.00% | - | Mar 31, 2024 |
Tyra Biosciences's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -0.14M shares, valued at -, as of undefined.
Tyra Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY ADVISOR SERIES VII | 0.07% | 604,900 | 308,300 | 103.94% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 419,443 | 7,600 | 1.85% | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 12,400 | - | - | Dec 31, 2023 |
| Vericimetry Funds | 0.02% | 2,640 | - | - | Dec 31, 2023 |
| FIDELITY SECURITIES FUND | 0.02% | 1,839,248 | 153,901 | 9.13% | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 20,587 | 5,360 | 35.20% | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,162 | - | - | Dec 31, 2023 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 24,587 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 866,984 | 281,804 | 48.16% | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 50,705 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 76,100 | -33,800 | -30.76% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 212,000 | -186,000 | -46.73% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 15,907 | 7,600 | 91.49% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 33,060 | 11,120 | 50.68% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 157,150 | 10,380 | 7.07% | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 36,093 | -1,664 | -4.41% | Dec 31, 2023 |
| ETF Series Solutions | 0.00% | 11,212 | 1,795 | 19.06% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 11,823 | -221 | -1.83% | Dec 31, 2023 |
| SCHWAB STRATEGIC TRUST | 0.00% | 76,686 | 479 | 0.63% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 940 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 7,492 | - | - | Dec 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 850 | - | - | Dec 31, 2023 |
| Federated Hermes Global Allocation Fund | 0.00% | 2,142 | 1,585 | 284.56% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 5,884 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 664 | - | - | Dec 31, 2023 |
| TIAA-CREF LIFE FUNDS | 0.00% | 356 | - | - | Dec 31, 2023 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 12,155 | 2,610 | 27.34% | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 7,595 | 7,595 | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 698 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,207 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 706 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 28,737 | - | - | Dec 29, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 61,827 | 7,016 | 12.80% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 127 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 34,696 | 263 | 0.76% | Dec 31, 2023 |
| ProFunds | 0.00% | 200 | 82 | 69.49% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 5,367 | -22 | -0.41% | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 40,648 | 574 | 1.43% | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 500 | - | - | Dec 29, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,120 | - | - | Dec 31, 2023 |
| RYDEX DYNAMIC FUNDS | 0.00% | 63 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,566 | -10 | -0.63% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 70 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 2,048 | 260 | 14.54% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 8 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 6,957 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 599 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,489 | 1,701 | 44.90% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,584 | -7 | -0.44% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 256 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 59 | 14 | 31.11% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 6,341 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 4,942 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 5,340 | -195 | -3.52% | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 979 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 4,419 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,546 | - | - | Dec 31, 2023 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,600 | - | - | Feb 29, 2024 |
Tyra Biosciences's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 604.90K shares, compromising 0.07% of its total assets.
Tyra Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 25 | -60.32% |
| 31 Dec, 23 | 63 | 8.62% |
| 30 Sep, 23 | 58 | -1.69% |
| 30 Jun, 23 | 59 | 13.46% |
| 31 Mar, 23 | 52 | 10.64% |
| 31 Dec, 22 | 47 | - |
| 30 Sep, 22 | 47 | 6.82% |
| 30 Jun, 22 | 44 | -4.35% |
| 31 Mar, 22 | 46 | 2.22% |
| 31 Dec, 21 | 45 | 73.08% |
| 30 Sep, 21 | 26 | - |
As of 31 Mar 24, 25 institutions are holding Tyra Biosciences's shares, representing a decrease of -60.32% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 7,632,256 | -78.66% |
| 31 Dec, 23 | 35,756,693 | -1.90% |
| 30 Sep, 23 | 36,450,761 | 0.66% |
| 30 Jun, 23 | 36,210,809 | 1.53% |
| 31 Mar, 23 | 35,666,024 | 1.21% |
| 31 Dec, 22 | 35,239,879 | -1.27% |
| 30 Sep, 22 | 35,693,315 | -0.10% |
| 30 Jun, 22 | 35,727,755 | -1.12% |
| 31 Mar, 22 | 36,133,976 | 2.73% |
| 31 Dec, 21 | 35,174,367 | 34.87% |
| 30 Sep, 21 | 26,080,764 | - |
Tyra Biosciences (TYRA) has 7.63M shares outstanding as of 31 Mar 24, down -78.66% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 17.76% | 0.26% |
| 31 Dec, 23 | 83.41% | 1.14% |
| 30 Sep, 23 | 85.59% | 1.17% |
| 30 Jun, 23 | 85.41% | 1.21% |
| 31 Mar, 23 | 84.13% | 1.19% |
| 31 Dec, 22 | 84.14% | 1.16% |
| 30 Sep, 22 | 84.99% | 1.16% |
| 30 Jun, 22 | 85.52% | 1.13% |
| 31 Mar, 22 | 86.96% | 1.20% |
| 31 Dec, 21 | 85.16% | 2.14% |
| 30 Sep, 21 | 63.14% | - |
As of 31 Mar 24, Tyra Biosciences is held by 17.76% institutional shareholders, representing a 0.26% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 17 | -45.16% |
| 31 Dec, 23 | 31 | 63.16% |
| 30 Sep, 23 | 19 | -32.14% |
| 30 Jun, 23 | 28 | - |
| 31 Mar, 23 | 28 | 64.71% |
| 31 Dec, 22 | 17 | -15.00% |
| 30 Sep, 22 | 20 | - |
| 30 Jun, 22 | 20 | 5.26% |
| 31 Mar, 22 | 19 | -45.71% |
| 31 Dec, 21 | 35 | 34.62% |
| 30 Sep, 21 | 26 | - |
17 institutional shareholders have increased their position in TYRA stock as of 31 Mar 24 compared to 31 in the previous quarter (a -45.16% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 4 | -66.67% |
| 31 Dec, 23 | 12 | -25.00% |
| 30 Sep, 23 | 16 | 14.29% |
| 30 Jun, 23 | 14 | 55.56% |
| 31 Mar, 23 | 9 | -18.18% |
| 31 Dec, 22 | 11 | -26.67% |
| 30 Sep, 22 | 15 | -6.25% |
| 30 Jun, 22 | 16 | -15.79% |
| 31 Mar, 22 | 19 | 171.43% |
| 31 Dec, 21 | 7 | - |
| 30 Sep, 21 | - | - |
4 institutional shareholders have reduced their position in TYRA stock as of 31 Mar 24 compared to 12 in the previous quarter (a -66.67% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 25 | -60.32% | 7,632,256 | -78.66% | 17.76% | 0.26% | 17 | -45.16% | 4 | -66.67% |
| 31 Dec, 23 | 63 | 8.62% | 35,756,693 | -1.90% | 83.41% | 1.14% | 31 | 63.16% | 12 | -25.00% |
| 30 Sep, 23 | 58 | -1.69% | 36,450,761 | 0.66% | 85.59% | 1.17% | 19 | -32.14% | 16 | 14.29% |
| 30 Jun, 23 | 59 | 13.46% | 36,210,809 | 1.53% | 85.41% | 1.21% | 28 | - | 14 | 55.56% |
| 31 Mar, 23 | 52 | 10.64% | 35,666,024 | 1.21% | 84.13% | 1.19% | 28 | 64.71% | 9 | -18.18% |
| 31 Dec, 22 | 47 | - | 35,239,879 | -1.27% | 84.14% | 1.16% | 17 | -15.00% | 11 | -26.67% |
| 30 Sep, 22 | 47 | 6.82% | 35,693,315 | -0.10% | 84.99% | 1.16% | 20 | - | 15 | -6.25% |
| 30 Jun, 22 | 44 | -4.35% | 35,727,755 | -1.12% | 85.52% | 1.13% | 20 | 5.26% | 16 | -15.79% |
| 31 Mar, 22 | 46 | 2.22% | 36,133,976 | 2.73% | 86.96% | 1.20% | 19 | -45.71% | 19 | 171.43% |
| 31 Dec, 21 | 45 | 73.08% | 35,174,367 | 34.87% | 85.16% | 2.14% | 35 | 34.62% | 7 | - |
| 30 Sep, 21 | 26 | - | 26,080,764 | - | 63.14% | - | 26 | - | - | - |
Tyra Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Tyra Biosciences's stock was made by Moran Susan on May 09 2024, selling - shares at - per share (valued at -).
Tyra Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 2 | 2 | 100.00% |
| Q1 2024 | 8 | 18 | 44.44% |
| Q3 2023 | 15 | 17 | 88.24% |
| Q2 2023 | 20 | 37 | 54.05% |
| Q1 2023 | 20 | 30 | 66.67% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 11 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | - | 3 | - |
| Q4 2021 | 15 | - | - |
| Q3 2021 | 23 | 50 | 46.00% |
2 total buy trades, and 2 total sell trades (buy/sell ratio of 1.00%) were made by Tyra Biosciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 17 | - |
| Q3 2023 | - | 9 | - |
| Q2 2023 | - | 25 | - |
| Q1 2023 | - | 12 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 5 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Tyra Biosciences's stocks.
Tyra Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| MLYS | Mineralys Therapeutics, Inc. |
| GRCL | Gracell Biotechnologies Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| DSGN | Design Therapeutics, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| PHVS | Pharvaris N.V. |
| CNTB | Connect Biopharma Holdings Limited |
| IKNA | Ikena Oncology, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| MOLN | Molecular Partners AG |
| RAPT | RAPT Therapeutics, Inc. |
TYRA Ownership FAQ
Who Owns Tyra Biosciences?
Tyra Biosciences is owned by institutional shareholders (17.76%), insiders (4.70%), and public (77.54%). The largest institutional shareholder of Tyra Biosciences is RA CAPITAL MANAGEMENT, L.P. (24.24% of total shares) and the top mutual fund owner is FIDELITY ADVISOR SERIES VII (0.07% of total shares).
Who are the major institutional shareholders of Tyra Biosciences?
Tyra Biosciences's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, BVF INC/IL, CANAAN PARTNERS XI LLC, and NEXTECH INVEST LTD.. The top five shareholders own together 69.80% of the company's share outstanding.
How many Tyra Biosciences shareholders are there?
As of Mar 2024, there are 25 institutional shareholders of Tyra Biosciences.
What percentage of Tyra Biosciences is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 10.42M shares of Tyra Biosciences, representing 24.24% of the company's total shares outstanding, valued at $170.83M (as of Mar 2024).
What percentage of Tyra Biosciences is owned by BOXER CAPITAL, LLC?
As of Mar 2024, BOXER CAPITAL, LLC holds 6.45M shares of Tyra Biosciences (TYRA), compromising 15.01% of the company, valued at $105.75M.
What percentage of Tyra Biosciences is owned by BVF INC/IL?
BVF INC/IL is the third largest holder of Tyra Biosciences. The company owns 4.66M of the company's shares outstanding (worth $76.44M).